scholarly article | Q13442814 |
P356 | DOI | 10.1111/JTH.13893 |
P698 | PubMed publication ID | 29168325 |
P50 | author | David Faraoni | Q64819139 |
P2093 | author name string | A Greinacher | |
J H Levy | |||
C M Samama | |||
A Godier | |||
P2860 | cites work | Safety of Factor XIII Concentrate: Analysis of More than 20 Years of Pharmacovigilance Data | Q31139049 |
Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications | Q33876266 | ||
Duration of anticoagulant therapy after a first episode of an unprovoked pulmonary embolus or deep vein thrombosis: guidance from the SSC of the ISTH. | Q34254243 | ||
Thrombin generation capacity of prothrombin complex concentrate in an in vitro dilutional model. | Q34734058 | ||
Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery | Q36142046 | ||
Fibrinogen levels in trauma patients during the first seven days after fibrinogen concentrate therapy: a retrospective study | Q36679150 | ||
Randomized evaluation of fibrinogen vs placebo in complex cardiovascular surgery (REPLACE): a double-blind phase III study of haemostatic therapy | Q37019701 | ||
Management of post‐partum haemorrhage | Q37808681 | ||
Biology of Factor XIII and clinical manifestations of Factor XIII deficiency | Q38038687 | ||
Prothrombin complex concentrates in trauma and perioperative bleeding | Q38345109 | ||
Effect of Fibrinogen Concentrate on Intraoperative Blood Loss Among Patients With Intraoperative Bleeding During High-Risk Cardiac Surgery: A Randomized Clinical Trial. | Q38380220 | ||
Efficacy and safety of recombinant factor XIII on reducing blood transfusions in cardiac surgery: a randomized, placebo-controlled, multicenter clinical trial | Q38448997 | ||
Fibrinogen Concentrates for Acquired Fibrinogen Deficiencies? | Q38801286 | ||
The effect of fibrinogen concentrate on perioperative bleeding in transurethral resection of the prostate: a double-blind placebo-controlled and randomized study. | Q39152703 | ||
Impact of Preemptive Fibrinogen Concentrate on Transfusion Requirements in Liver Transplantation: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial | Q39994821 | ||
Preoperative supplementation with fibrinogen concentrate in cardiac surgery: A randomized controlled study | Q40312549 | ||
Recombinant factor XIII: a safe and novel treatment for congenital factor XIII deficiency | Q45878100 | ||
Increasing concentrations of prothrombin complex concentrate induce disseminated intravascular coagulation in a pig model of coagulopathy with blunt liver injury | Q46100251 | ||
Reversal of trauma-induced coagulopathy using first-line coagulation factor concentrates or fresh frozen plasma (RETIC): a single-centre, parallel-group, open-label, randomised trial. | Q47382691 | ||
Pre-emptive treatment with fibrinogen concentrate for postpartum haemorrhage: randomized controlled trial | Q47762680 | ||
Factor XIII deficiency and postoperative hemorrhage after neurosurgical procedures | Q49151182 | ||
Reduced mortality by meeting guideline criteria before using recombinant activated factor VII in severe trauma patients with massive bleeding | Q50219204 | ||
Fibrinogen in the initial resuscitation of severe trauma (FiiRST): a randomized feasibility trial. | Q53840501 | ||
P433 | issue | 1 | |
P304 | page(s) | 170-174 | |
P577 | publication date | 2017-11-23 | |
P1433 | published in | Journal of Thrombosis and Haemostasis | Q6296004 |
P1476 | title | Use of factor concentrates for the management of perioperative bleeding: guidance from the SSC of the ISTH | |
P478 | volume | 16 |
Q89943293 | Impaired platelet-dependent thrombin generation associated with thrombocytopenia is improved by prothrombin complex concentrates in vitro |
Q93092226 | Successful Use of Recombinant Activated Factor VII to Reverse Ticagrelor-Induced Bleeding Risk: A Case Report |
Q64111058 | The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition |
Search more.